Spending-bill provision won't protect biotech firms like critics say

04/9/2013 | Bloomberg

The hysteria over a biotech crop provision signed into law last month has no basis because there's no truth to critics' claims about the law, Bloomberg View columnist Ramesh Ponnuru writes. The law's real impact is modest, and it would permit farmers to continue using products that are safe in case of frivolous lawsuits, Ponnuru writes.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ